Pawel Przewiezlikowski

Pawel Przewiezlikowski's work experience includes serving as the Chief Executive Officer and Co-Founder of Ryvu Therapeutics since 2007. Pawel also held the position of President of the Supervisory Board at Ardigen starting in 2016. From 2007 to 2019, they served as the CEO and Co-Founder of Selvita. Additionally, they were a Member of the Supervisory Board at Read-Gene from 2008 to 2011. Prior to these roles, Pawel Przewiezlikowski was a Member of the Management Board at ComArch S.A., starting as a systems analyst in 1994 and eventually becoming the manager of a division comprising financial services, retail, and FMCG markets. Pawel was also the founder, CEO, and Vice President of the Supervisory Board at Interia.pl, a prominent internet portal in Poland, from 1999 to 2007.

Pawel Przewiezlikowski's education history begins in 1986 when they attended I Liceum Krola Kazimierza Wielkiego Olkusz. Pawel studied Mathematics-physics during their time there, and completed their high school education in 1990. Following this, they enrolled at AGH University of Krakow from 1990 to 1995, where they pursued a degree in Computer Science and received their Master of Science (MSc) degree. In 1994, they briefly attended Technische Universität Berlin to further study Computer Science, but did not obtain a degree from this institution. In 1996, Pawel Przewiezlikowski went on to complete their education by pursuing a Master of Business Administration (MBA) degree at Teesside University, concluding their studies in 1999.